| Commercialising Emerging Technologies (COMET) |
| COMET is a grants program that supports businesses and individuals increase the commercialisation of innovative products, processes and services. This program is part of the $3 billion Innovation Statement, Backing Australia's Ability. |
|
| Industry Cooperative Innovation Program (ICIP) |
| Industry Cooperative Innovation Program (ICIP) is a $25 million commitment announced on 8 October 2004 in From Strength to Strength: the Coalition's Policy for Australian Industry. The program aims to encourage business-to-business cooperation on innovation projects that enhance productivity, growth and the international competitiveness of Australian industries. |
| |
| Innovation Access Program |
| The Innovation Access Program (IAccP) - Industry has concluded with activities supporting technology access, diffusion and industry collaboration now covered by Commercial Ready and the Industry Cooperative Innovation Program. Contractual obligations and existing administrative arrangements will continue for those applicants who are still undertaking their projects. |
| |
| Innovation Investment Fund (IIF) |
| The Australian Government, in partnership with the private sector, has established a number of venture capital funds under the Innovation Investment Fund (IIF) initiative, to invest in small technology based companies, commercialising Australian R&D. By demonstrating the returns achievable from investing in such companies, IIF aims to encourage additional private sector investment. |
| |
| Mammalian Cell Production Facility |
|
Information about a one-off $10 million grant to support the establishment of a small-scale mammalian cell production facility in Australia to bridge the infrastructure gap in the national biotechnology manufacturing value chain. |
| |
| National Australian Technology Showcase (ATS) |
| Australian Technology Showcase is a national and international campaign designed to promote leading-edge Australian technology and the skills of the companies that produce them. |
| |
| Pharmaceuticals Partnerships Program (P3) |
| The Pharmaceuticals Partnerships Program (P) is aimed at increasing the amount of high quality pharmaceutical R&D activity in Australia throughout the entire value chain including biotechnology, originator and generic medicines companies. |
| |
| Pooled Development Funds (PDF) Program |
PDF registration is no longer available (A PDF is a venture capital fund).
Australian businesses looking to fund their growth may be able to access funding from a PDF if their total assets are no more than $50m and their primary activity is not retail or property development. |
| |
| Pre-Seed Fund |
| The pre-seed fund for universities and public sector research agencies is to address the gap between scientific discoveries and commercialisation. It assists R&D activities build links with finance and business communities. This program forms part of Innovation Statement, Backing Australia's Ability. |
| |
| R&D Tax Concession |
R&D Tax Concession is a broad-based, market driven tax concession which allows companies to deduct qualifying expenditure incurred on R&D activities. The R&D Tax Offset, 175% R&D Premium Tax concession and effective life treatment for R&D plant will continue under the new 'Backing Australia's Ability Building - Building Our Future through Science and Innovation' package.
The Industry Research and Development Board (Overseas Research and Development Activities) Guidelines 2004. The revised overseas guidelines came into effect on 13 May 2004. They have now passed through the parliamentary process and are in full force.
The amendments clarify that the R&D activities undertaken must form part of a larger R&D project in Australia; that the resources necessary to undertake the R&D overseas are not available in Australia; and that the 10% limit applies to expenditure only. The new guidelines also clarify the requirements to be met by firms seeking certification for overseas R&D activities; ensure consistency with the IR&D Act; and generally improve its operation. A full copy of the guidelines is available.
Information about an evaluation of the R&D Tax Concession program is available. |
| |
| South Australia Innovation and Investment Fund (SAIIF) |
|
This discretionary grant program has total funding of $30 million (less administration costs) contributed by the Australian and South Australian Governments. It is designed to fund innovative job creation projects to strengthen South Australia's manufacturing and technology base. All industry sectors are eligible to apply including the information technology and services sectors.
Information about the SAIIF is available. |